| Résumé : |
Recent clinical studies have demonstrated that a single subpsychotomimetic dose of ketamine, an ionotropic glutamatergic N-methyl-d-aspartate (NMDA) receptor antagonist, produces a rapid antidepressant response in patients with major depressive disorder, with effects lasting up to 2 weeks. Despite enthusiasm about this unexpected efficacy of ketamine, its widespread use as a fast-acting antidepressant in routine clinical settings is curtailed by its abuse potential as well as possible psychotomimetic effects. |
Ajouter le résultat dans votre panier Faire une suggestion Affiner la recherche Interroger des sources externesSynaptic Mechanisms Underlying Rapid Antidepressant Action of Ketamine in The American Journal of Psychiatry, Vol.169-N°11 Novembe (2012)
